SV Life Sciences Fund VI, L.P. — Form D
SV Life Sciences Fund VI, L.P. of BOSTON, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2015-05-26. The offering totals $400.0M. Industry: Pooled Investment Fund.
Offering
- Filed: 2015-05-26
- Form: D
- Accession: 0001642251-15-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $400.0M
- Remaining: $400.0M
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-240550
Issuer
- Name: SV Life Sciences Fund VI, L.P.
- CIK: 0001642251
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: C/O SV LIFE SCIENCES ADVISERS LLC, BOSTON, MA, 02108
- Phone: (617) 367-8100
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| THOMAS FLYNN | Executive Officer | DENVER, CO |
| Michael Ross | Executive Officer | South San Francisco, CA |
| Paul LaViolette | Executive Officer | Seattle, WA |
| James Garvey | Executive Officer | Chicago, IL |
| Kate Bingham | Executive Officer | London, X0 |
| DAVID MILNE | Executive Officer | San Clemente, CA |
| Eugene Hill | Executive Officer | Boston, MA |
| N/A SV Life Sciences Fund VI (GP), L.P. | Executive Officer | Boston, MA |
| N/A SVLSF VI, LLC | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More